Table 1 Tumour patients characteristics
All RCC | % | ccRCC | % | ccRCC surv. group | % | |
|---|---|---|---|---|---|---|
Total cases | 111 | 80 | 37 | |||
Histology | ||||||
ccRCC | 80 | 72.1 | 80 | 100 | 37 | 100 |
papRCC | 23 | 20.7 | 0 | 0 | 0 | 0 |
Chrom. RCC | 4 | 3.6 | 0 | 0 | 0 | 0 |
Not class. | 4 | 3.6 | 0 | 0 | 0 | 0 |
Sex | ||||||
Female | 38 | 34.2 | 30 | 37.5 | 15 | 40.5 |
Male | 73 | 65.8 | 50 | 62.5 | 22 | 59.5 |
Age | ||||||
Median (years) | 65 | 64 | 65 | |||
Distant metastasis | ||||||
M0 | 86 | 77.5 | 60 | 75 | 28 | 75.7 |
M+ | 25 | 22.5 | 20 | 25 | 9 | 24.3 |
Lymph node metastasis | ||||||
N0 | 98 | 88.3 | 73 | 91.3 | 35 | 94.6 |
N+ | 13 | 11.7 | 7 | 8.8 | 2 | 5.4 |
T-classification | ||||||
pT1 | 11 | 9.9 | 8 | 10 | 1 | 2.7 |
pT1a | 32 | 28.8 | 21 | 26.3 | 12 | 32.4 |
pT1b | 19 | 17.1 | 14 | 17.5 | 7 | 18.9 |
pT2 | 7 | 6.3 | 5 | 6.3 | 2 | 5.4 |
pT3 | 5 | 4.5 | 2 | 2.5 | 1 | 2.7 |
pT3a | 9 | 8.1 | 7 | 8.8 | 2 | 5.4 |
pT3b/c | 23 | 20.7 | 21 | 26.3 | 11 | 29.7 |
pT4 | 1 | 0.9 | 0 | 0 | 0 | 0 |
NA | 4 | 3.6 | 2 | 2.5 | 1 | 2.7 |
Differentiation | ||||||
G1 | 22 | 19.8 | 19 | 23.8 | 5 | 13.5 |
G1–2 | 14 | 12.6 | 9 | 11.3 | 4 | 10.8 |
G2 | 56 | 50.5 | 38 | 47.5 | 21 | 56.8 |
G2–3 | 8 | 7.2 | 4 | 5 | 2 | 5.4 |
G3 | 11 | 9.9 | 10 | 12.5 | 5 | 13.5 |
State of disease | ||||||
Loc. diseasea | 59 | 53.2 | 39 | 48.8 | 17 | 45.9 |
Adv. diseaseb | 51 | 45.9 | 41 | 51.3 | 20 | 54.1 |
NA | 1 | 0.9 | 0 | 0 | 0 | 0 |
Paired samples | ||||||
All RCC | 77 | |||||
ccRCC | 58 | |||||
